AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 278: G390-G399, 2000;
0193-1857/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (54)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, P.
Right arrow Articles by Wang, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, P.
Right arrow Articles by Wang, T. C.
Vol. 278, Issue 3, G390-G399, March 2000

Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM

Pomila Singh1, Marco Velasco2, Randall Given1, Michael Wargovich2, Andrea Varro3, and Timothy C. Wang4

1 Department of Anatomy and Neurosciences, University of Texas Medical Branch, Galveston, Texas 77555-1043; 2 Department of Digestive Diseases and Gastrointestinal Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030; 3 Physiology Department, University of Liverpool, Liverpool L69 3BX, United Kingdom; and 4 Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts 02114

Recent studies show that nonamidated gastrins (Gly-gastrin and progastrin) stimulate colonic proliferation. However, the role of nonamidated vs. amidated gastrins in colon carcinogenesis has not been defined. We measured intermediate markers of carcinogenesis in transgenic mice overexpressing either progastrin (hGAS) or amidated gastrin (INS-GAS) in response to azoxymethane (AOM). The hGAS mice showed significantly higher numbers of aberrant crypt foci (140-200% increase) compared with that in wild-type (WT) and INS-GAS mice (P < 0.05) after AOM treatment. The bromodeoxyuridine-labeling index of colonic crypts also was significantly elevated in hGAS mice vs. that in WT and INS-GAS mice. The results therefore provide evidence for a mitogenic and cocarcinogenic role of nonamidated gastrins (progastrin), which is apparently not shared by the amidated gastrins. Although nonamidated gastrins are now believed to mediate mitogenic effects via novel receptors, amidated gastrins mediate biological effects via different receptor subtypes, which may explain the difference in the cocarcinogenic potential of nonamidated vs. amidated gastrins. In conclusion, our results provide strong support for a cocarcinogenic role for nonamidated gastrins in colon carcinogenesis.

transgenic mice


This article has been cited by other articles:


Home page
 Cancer Res.Home page
W. Rengifo-Cam, S. Umar, S. Sarkar, and P. Singh
Antiapoptotic Effects of Progastrin on Pancreatic Cancer Cells Are Mediated by Sustained Activation of Nuclear Factor-{kappa}B
Cancer Res., August 1, 2007; 67(15): 7266 - 7274.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
M. Dufresne, C. Seva, and D. Fourmy
Cholecystokinin and gastrin receptors.
Physiol Rev, July 1, 2006; 86(3): 805 - 847.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
P. D. Ottewell, A. Varro, G. J. Dockray, C. M. Kirton, A. J. M. Watson, T. C. Wang, R. Dimaline, and D. M. Pritchard
COOH-terminal 26-amino acid residues of progastrin are sufficient for stimulation of mitosis in murine colonic epithelium in vivo
Am J Physiol Gastrointest Liver Physiol, March 1, 2005; 288(3): G541 - G549.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Cui, T. J. Koh, D. Chen, C.-M. Zhao, S. Takaishi, G. J. Dockray, A. Varro, A. B. Rogers, J. G. Fox, and T. C. Wang
Overexpression of Glycine-Extended Gastrin Inhibits Parietal Cell Loss and Atrophy in the Mouse Stomach
Cancer Res., November 15, 2004; 64(22): 8160 - 8166.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. J. Koh, J. K. Field, A. Varro, T. Liloglou, P. Fielding, G. Cui, J. Houghton, G. J. Dockray, and T. C. Wang
Glycine-Extended Gastrin Promotes the Growth of Lung Cancer
Cancer Res., January 1, 2004; 64(1): 196 - 201.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. Wu, A. Owlia, and P. Singh
Precursor peptide progastrin1-80 reduces apoptosis of intestinal epithelial cells and upregulates cytochrome c oxidase Vb levels and synthesis of ATP
Am J Physiol Gastrointest Liver Physiol, December 1, 2003; 285(6): G1097 - G1110.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
R. P. Thomas, M. R. Hellmich, C. M. Townsend Jr., and B. M. Evers
Role of Gastrointestinal Hormones in the Proliferation of Normal and Neoplastic Tissues
Endocr. Rev., October 1, 2003; 24(5): 571 - 599.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
P. Singh, X. Lu, S. Cobb, B. T. Miller, N. Tarasova, A. Varro, and A. Owlia
Progastrin1-80 stimulates growth of intestinal epithelial cells in vitro via high-affinity binding sites
Am J Physiol Gastrointest Liver Physiol, February 1, 2003; 284(2): G328 - G339.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. A. Watson and A. M. Smith
Hypergastrinemia Promotes Adenoma Progression in the APCMin-/+ Mouse Model of Familial Adenomatous Polyposis
Cancer Res., January 1, 2001; 61(2): 625 - 631.
[Abstract] [Full Text]

Home page
 GutHome page
G J DOCKRAY
Gastrin, growth, and colon neoplasia
Gut, December 1, 2000; 47(6): 747 - 748.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online